Association Between Social Vulnerability and Streptococcus Pneumoniae Antimicrobial Resistance in US Adults

Overview

Journal Clin Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2024 Mar 14

PMID 38483935

Authors

Salini Mohanty

Gang Ye

Charles Sheets

Nicole Cossrow

Kalvin C Yu

Meghan White

Kenneth P Klinker

Vikas Gupta

Affiliations

Soon will be listed here.

Abstract

Background: Growing evidence indicates antimicrobial resistance disproportionately affects individuals living in socially vulnerable areas. This study evaluated the association between the CDC/ATSDR Social Vulnerability Index (SVI) and Streptococcus pneumoniae (SP) antimicrobial resistance (AMR) in the United States.

Methods: Adult patients ≥18 years with 30-day nonduplicate SP isolates from ambulatory/hospital settings from January 2011 to December 2022 with zip codes of residence were evaluated across 177 facilities in the BD Insights Research Database. Isolates were identified as SP AMR if they were non-susceptible to ≥1 antibiotic class (macrolide, tetracycline, extended-spectrum cephalosporins, or penicillin). Associations between SP AMR and SVI score (overall and themes) were evaluated using generalized estimating equations with repeated measurements within county to account for within-cluster correlations.

Results: Of 8008 unique SP isolates from 574 US counties across 39 states, the overall proportion of AMR was 49.9%. A significant association between socioeconomic status (SES) theme and SP AMR was detected with higher SES theme SVI score (indicating greater social vulnerability) associated with greater risk of AMR. On average, a decile increase of SES, indicating greater vulnerability, was associated with a 1.28% increased risk of AMR (95% confidence interval [CI], .61%, 1.95%; P = .0002). A decile increase of household characteristic score was associated with a 0.81% increased risk in SP AMR (95% CI, .13%, 1.49%; P = .0197). There was no association between racial/ethnic minority status, housing type and transportation theme, or overall SVI score and SP AMR.

Conclusions: SES and household characteristics were the SVI themes most associated with SP AMR.

Citing Articles

Bactofencin YH, a novel bacteriocin with high inhibitory activity against clinical Streptococcus species.

Wu H, Arima J, Kuan C, Tsai Y, Lee Y, Chan C World J Microbiol Biotechnol. 2024; 40(10):290.

PMID: 39102120 DOI: 10.1007/s11274-024-04100-0.

References

Dalton A, Weber Z, Allen K, Stenehjem E, Irving S, Spark T . Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness. Clin Infect Dis. 2023; 76(9):1615-1625. PMC: 10949185. DOI: 10.1093/cid/ciad003. View

. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022; 399(10325):629-655. PMC: 8841637. DOI: 10.1016/S0140-6736(21)02724-0. View

Gupta V, Yu K, Schranz J, Gelone S . A Multicenter Evaluation of the US Prevalence and Regional Variation in Macrolide-Resistant in Ambulatory and Hospitalized Adult Patients in the United States. Open Forum Infect Dis. 2021; 8(7):ofab063. PMC: 8266646. DOI: 10.1093/ofid/ofab063. View

Bajema K, Gierke R, Farley M, Schaffner W, Thomas A, Reingold A . Impact of Pneumococcal Conjugate Vaccines on Antibiotic-Nonsusceptible Invasive Pneumococcal Disease in the United States. J Infect Dis. 2022; 226(2):342-351. DOI: 10.1093/infdis/jiac154. View

See I, Wesson P, Gualandi N, Dumyati G, Harrison L, Lesher L . Socioeconomic Factors Explain Racial Disparities in Invasive Community-Associated Methicillin-Resistant Staphylococcus aureus Disease Rates. Clin Infect Dis. 2017; 64(5):597-604. PMC: 5656382. DOI: 10.1093/cid/ciw808. View

Raman R, Brennan J, Ndi D, Sloan C, Markus T, Schaffner W . Marked Reduction of Socioeconomic and Racial Disparities in Invasive Pneumococcal Disease Associated With Conjugate Pneumococcal Vaccines. J Infect Dis. 2020; 223(7):1250-1259. DOI: 10.1093/infdis/jiaa515. View

McLaughlin J, Swerdlow D, Khan F, Will O, Curry A, Snow V . Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United States. Hum Vaccin Immunother. 2019; 15(4):841-849. PMC: 6605819. DOI: 10.1080/21645515.2018.1564434. View

Suaya J, Mendes R, Sings H, Arguedas A, Reinert R, Jodar L . Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 2009‒2017. J Infect. 2020; 81(4):557-566. DOI: 10.1016/j.jinf.2020.07.035. View

Minssen T, Outterson K, Rogers Van Katwyk S, Batista P, Chandler C, Ciabuschi F . Social, cultural and economic aspects of antimicrobial resistance. Bull World Health Organ. 2020; 98(12):823-823A. PMC: 7716096. DOI: 10.2471/BLT.20.275875. View

10.

Biggs E, Maloney P, Rung A, Peters E, Robinson W . The Relationship Between Social Vulnerability and COVID-19 Incidence Among Louisiana Census Tracts. Front Public Health. 2021; 8:617976. PMC: 7856141. DOI: 10.3389/fpubh.2020.617976. View

11.

Nowalk M, Wateska A, Lin C, Schaffner W, Harrison L, Zimmerman R . Racial Disparities in Adult Pneumococcal Vaccination Indications and Pneumococcal Hospitalizations in the U.S. J Natl Med Assoc. 2019; 111(5):540-545. PMC: 6888932. DOI: 10.1016/j.jnma.2019.04.011. View

12.

King T, Schindler R, Chavda S, Conly J . Dimensions of poverty as risk factors for antimicrobial resistant organisms in Canada: a structured narrative review. Antimicrob Resist Infect Control. 2022; 11(1):18. PMC: 8785485. DOI: 10.1186/s13756-022-01059-1. View

13.

Bevan G, Pandey A, Griggs S, Dalton J, Zidar D, Patel S . Neighborhood-level Social Vulnerability and Prevalence of Cardiovascular Risk Factors and Coronary Heart Disease. Curr Probl Cardiol. 2022; 48(8):101182. PMC: 9875801. DOI: 10.1016/j.cpcardiol.2022.101182. View

14.

Lemay J, Ricketson L, Zwicker L, Kellner J . Homelessness in Adults with Invasive Pneumococcal Disease (IPD) in Calgary, Canada. Open Forum Infect Dis. 2019; 6(10). PMC: 6767971. DOI: 10.1093/ofid/ofz362. View

15.

Kim S, Bostwick W . Social Vulnerability and Racial Inequality in COVID-19 Deaths in Chicago. Health Educ Behav. 2020; 47(4):509-513. PMC: 8183499. DOI: 10.1177/1090198120929677. View

16.

Ismail S, Tunis M, Zhao L, Quach C . Navigating inequities: a roadmap out of the pandemic. BMJ Glob Health. 2021; 6(1). PMC: 7825252. DOI: 10.1136/bmjgh-2020-004087. View

17.

Humphries R, Abbott A, Hindler J . Understanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories. J Clin Microbiol. 2019; 57(6). PMC: 6535595. DOI: 10.1128/JCM.00203-19. View

18.

Savoldi A, Carrara E, Gladstone B, Azzini A, Gopel S, Tacconelli E . Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list. J Antimicrob Chemother. 2019; 74(12):3619-3625. DOI: 10.1093/jac/dkz381. View

19.

. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022; 400(10369):2221-2248. PMC: 9763654. DOI: 10.1016/S0140-6736(22)02185-7. View

20.

Gopichandran V . Reducing the Ethical Burdens of Antimicrobial Stewardship using a Social Determinants Approach. Asian Bioeth Rev. 2022; 14(2):183-190. PMC: 8986926. DOI: 10.1007/s41649-022-00202-9. View